A detailed history of Congress Wealth Management LLC transactions in Dexcom Inc stock. As of the latest transaction made, Congress Wealth Management LLC holds 17,542 shares of DXCM stock, worth $1.27 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
17,542
Previous 176,838 90.08%
Holding current value
$1.27 Million
Previous $20 Million 94.14%
% of portfolio
0.02%
Previous 0.33%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$64.0 - $116.06 $10.2 Million - $18.5 Million
-159,296 Reduced 90.08%
17,542 $1.18 Million
Q2 2024

Aug 13, 2024

BUY
$110.31 - $140.45 $902,446 - $1.15 Million
8,181 Added 4.85%
176,838 $20 Million
Q1 2024

Apr 18, 2024

BUY
$114.22 - $140.1 $108,737 - $133,375
952 Added 0.57%
168,657 $23.4 Million
Q4 2023

Feb 09, 2024

BUY
$75.49 - $124.16 $10.6 Million - $17.5 Million
141,065 Added 529.52%
167,705 $20.8 Million
Q3 2023

Oct 30, 2023

SELL
$86.06 - $137.93 $187,094 - $299,859
-2,174 Reduced 7.54%
26,640 $2.49 Million
Q2 2023

Jul 13, 2023

SELL
$112.47 - $130.98 $35,765 - $41,651
-318 Reduced 1.09%
28,814 $3.7 Million
Q1 2023

Apr 14, 2023

SELL
$104.0 - $122.92 $443,768 - $524,499
-4,267 Reduced 12.78%
29,132 $3.38 Million
Q4 2022

Feb 02, 2023

SELL
$84.98 - $122.67 $373,657 - $539,379
-4,397 Reduced 11.63%
33,399 $3.78 Million
Q3 2022

Nov 08, 2022

SELL
$76.35 - $94.18 $935,745 - $1.15 Million
-12,256 Reduced 24.49%
37,796 $3.04 Million
Q2 2022

Aug 11, 2022

BUY
$67.99 - $132.89 $2.32 Million - $4.54 Million
34,142 Added 214.59%
50,052 $3.73 Million
Q1 2022

May 16, 2022

BUY
$94.08 - $130.2 $4,421 - $6,119
47 Added 0.3%
15,910 $8.14 Million
Q4 2021

Feb 04, 2022

BUY
$129.87 - $162.82 $2.06 Million - $2.58 Million
15,863 New
15,863 $8.52 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $28B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Congress Wealth Management LLC Portfolio

Follow Congress Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Congress Wealth Management LLC , based on Form 13F filings with the SEC.

News

Stay updated on Congress Wealth Management LLC with notifications on news.